Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild and Moderate Atopic Dermatitis Patients”

Showing 7 of 0 results

Not applicableStudy completedNCT04976868
What this trial is testing

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Mylan Inc. 130
Testing effectiveness (Phase 2)Study completedNCT06024499
What this trial is testing

Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaAtopic Dermatitis of Scalp
Shaperon 210
Testing effectiveness (Phase 2)Study completedNCT04737304
What this trial is testing

A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
BenevolentAI Bio 123
Early research (Phase 1)UnknownNCT05843422
What this trial is testing

A First-in-Human Study of QY211 Gel in Adult Subjects

Who this might be right for
Atopic Dermatitis
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 56
Not applicableStudy completedNCT01948869
What this trial is testing

Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bayer 35
Testing effectiveness (Phase 2)Study completedNCT02655679
What this trial is testing

An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Vitae Pharmaceuticals, Inc. 104
Post-approval studies (Phase 4)Study completedNCT00509990
What this trial is testing

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 200

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation